Cargando…

Treatment of epilepsy in China: Formal or informal

Antiepileptic drugs are the preferred treatment approach for epileptic patients. However, informal treatment is important for intractable epilepsy. In this study, 500 epileptic patients were recruited from the General Hospital of Beijing Military Area Command of Chinese PLA during the period of Octo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jianming, Liu, Zhiliang, Chen, Tao, Xu, Ruxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145945/
https://www.ncbi.nlm.nih.gov/pubmed/25206653
http://dx.doi.org/10.3969/j.issn.1673-5374.2013.35.006
_version_ 1782332246955393024
author Liu, Jianming
Liu, Zhiliang
Chen, Tao
Xu, Ruxiang
author_facet Liu, Jianming
Liu, Zhiliang
Chen, Tao
Xu, Ruxiang
author_sort Liu, Jianming
collection PubMed
description Antiepileptic drugs are the preferred treatment approach for epileptic patients. However, informal treatment is important for intractable epilepsy. In this study, 500 epileptic patients were recruited from the General Hospital of Beijing Military Area Command of Chinese PLA during the period of October 2009 to January 2012. These involved patients that had been medically treated for at least 1 year. Information on the initial treatment and changes to treatment regimens for each patient was collected through questionnaires. The survey results showed that 52.3% of the epileptic patients searched for treatment after the first seizure, and the mean numbers of seizures was 12.8; 59.8% of the epileptic patients were diagnosed at the first visit, and the mean onset time was 17 months after the first seizure. After diagnosis, patients were treated for an average of 20 days, and the median time was 1 day. Formal anti-epileptic drugs were selected as the first treatment regimen by 67.8% of patients, and 77.5% of these drugs were monotherapies. The mean and median numbers of seizure were respectively 36.9 and 3.0 times before the first regimen was changed. The regimen was changed within the first 6 months by 46.6% of patients, and after the first and second years of treatment, the proportions increased to 54.0% and 71.8%, respectively. In total, 78.5% of the regimens were changed to informal treatments. The informal treatment of epilepsy in China is common, being initiated by either patients or physicians. Enhancing epileptic treatment services in hospital, improving physicians’ professional quality, and strengthening health propaganda may promote the normalization of drug treatment of epilepsy in China.
format Online
Article
Text
id pubmed-4145945
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-41459452014-09-09 Treatment of epilepsy in China: Formal or informal Liu, Jianming Liu, Zhiliang Chen, Tao Xu, Ruxiang Neural Regen Res Research and Report Article: Neurodegenerative Disease and Neural Regeneration Antiepileptic drugs are the preferred treatment approach for epileptic patients. However, informal treatment is important for intractable epilepsy. In this study, 500 epileptic patients were recruited from the General Hospital of Beijing Military Area Command of Chinese PLA during the period of October 2009 to January 2012. These involved patients that had been medically treated for at least 1 year. Information on the initial treatment and changes to treatment regimens for each patient was collected through questionnaires. The survey results showed that 52.3% of the epileptic patients searched for treatment after the first seizure, and the mean numbers of seizures was 12.8; 59.8% of the epileptic patients were diagnosed at the first visit, and the mean onset time was 17 months after the first seizure. After diagnosis, patients were treated for an average of 20 days, and the median time was 1 day. Formal anti-epileptic drugs were selected as the first treatment regimen by 67.8% of patients, and 77.5% of these drugs were monotherapies. The mean and median numbers of seizure were respectively 36.9 and 3.0 times before the first regimen was changed. The regimen was changed within the first 6 months by 46.6% of patients, and after the first and second years of treatment, the proportions increased to 54.0% and 71.8%, respectively. In total, 78.5% of the regimens were changed to informal treatments. The informal treatment of epilepsy in China is common, being initiated by either patients or physicians. Enhancing epileptic treatment services in hospital, improving physicians’ professional quality, and strengthening health propaganda may promote the normalization of drug treatment of epilepsy in China. Medknow Publications & Media Pvt Ltd 2013-12-15 /pmc/articles/PMC4145945/ /pubmed/25206653 http://dx.doi.org/10.3969/j.issn.1673-5374.2013.35.006 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research and Report Article: Neurodegenerative Disease and Neural Regeneration
Liu, Jianming
Liu, Zhiliang
Chen, Tao
Xu, Ruxiang
Treatment of epilepsy in China: Formal or informal
title Treatment of epilepsy in China: Formal or informal
title_full Treatment of epilepsy in China: Formal or informal
title_fullStr Treatment of epilepsy in China: Formal or informal
title_full_unstemmed Treatment of epilepsy in China: Formal or informal
title_short Treatment of epilepsy in China: Formal or informal
title_sort treatment of epilepsy in china: formal or informal
topic Research and Report Article: Neurodegenerative Disease and Neural Regeneration
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145945/
https://www.ncbi.nlm.nih.gov/pubmed/25206653
http://dx.doi.org/10.3969/j.issn.1673-5374.2013.35.006
work_keys_str_mv AT liujianming treatmentofepilepsyinchinaformalorinformal
AT liuzhiliang treatmentofepilepsyinchinaformalorinformal
AT chentao treatmentofepilepsyinchinaformalorinformal
AT xuruxiang treatmentofepilepsyinchinaformalorinformal